SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences board to consider interim dividend

23 Jan 2017 Evaluate

Suven Life Sciences has informed that a Board Meeting of the Company will be held on February 01, 2017, to consider, take on record and approve the Un-audited Financial Results of the Company under Ind AS for the quarter and nine months ended December 31, 2016, to consider declaration of Interim Dividend, if any, for the financial year 2016-17 and related matters etc. and Further, the trading window for dealing in the securities of the Company is closed from January 23, 2017 to February 03, 2017. Trading window will be opened from February 04, 2017.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

195.90 -0.10 (-0.05%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×